Evaluation of insulin like growth factor-1 (IGF-1) level and its impact on muscle and bone mineral density in frail elderly male

Archives of Gerontology and Geriatrics

Volumn 60, Issue 1, 2015, Pages 124-127

  Mohamad, Magda I ^a   Khater, Mohamed S ^a  

^a AIN SHAMS UNIVERSITY   (Egypt)

Author keywords

Anthropometric measures; Bone mineral density; Elderly male; Frailty; IGF 1

Indexed keywords

SOMATOMEDIN C;

ADULT; AGE; AGED; ARM CIRCUMFERENCE; ARTICLE; BONE DENSITY; COMORBIDITY; CONTROLLED STUDY; FEMUR; FRAIL ELDERLY; GRIP STRENGTH; HUMAN; MALE; MID CALF CIRCUMFERENCE; MUSCLE MASS; OSTEOPENIA; OSTEOPOROSIS; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; ANTHROPOMETRY; EGYPT; GERIATRIC ASSESSMENT; HAND STRENGTH; METABOLISM; MIDDLE AGED; MUSCLE; PHYSIOLOGY; PROCEDURES; RISK; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTHROPOMETRY; BONE DENSITY; EGYPT; FRAIL ELDERLY; GERIATRIC ASSESSMENT; HAND STRENGTH; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED; MUSCLES; ODDS RATIO; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 84918500735     PISSN: 01674943     EISSN: 18726976     Source Type: Journal    
DOI: 10.1016/j.archger.2014.08.011     Document Type: Article

References (30)

1. Amin S., Riggs B.L., Atkinson E.J., Oberg A.L., Melton L.J., Khosla S., et al. A potentially deleterious role of IGFBP-2 on bone density in aging men and women. Journal of Bone and Mineral Research 2004, 19:1075-1083.
2. Amin S., Riggs B.L., Melton L.J., Achenbach S.J., Atkinson E.J., Khosla S. High serum IGFBP-2 is predictive of increased bone turnover in aging men and women. Journal of Bone and Mineral Research 2007, 22:799-807.
3. Bortz W.M. A conceptual framework of frailty: A review. Journals of Gerontology Series A: Biological Sciences and Medical Sciences 2002, 57:283-288.
4. Brugts M.P., Ranke M.B., Hofland L.J., Van derWansem K., Weber K., Frystyk J., et al. Normal values of circulating insulin like growth factor-I bioactivity in the healthy population: Comparison with five widely used IGF-I immunoassays. Journal of Clinical Endocrinology and Metabolism 2008, 93:2539-2545.
5. Cappola A.R., Xue Q.L., Ferrucci L., Guralnik J.M., Volpato S., Fried L.P., et al. Insulin-like growth factor I and interleukin-6 contribute synergistically to disability and mortality in older women. Journal of Clinical Endocrinology and Metabolism 2003, 88:2019-2025.
6. Chen X.L., Lee K., Hartzell D.L., Dean R.G., Hausman G.J., McGraw R.A., et al. Adipocyte insensitivity to insulin in growth hormone-transgenic mice. Biochemical and Biophysical Research Communications 2001, 283:933-937.
7. Crane J.L., Cao X. Function of matrix IGF-1 in coupling bone resorption and formation. Journal of Molecular Medicine 2014, 92(2):107-115.
8. El-Okl M.A. Prevalence of Alzheimer dementia and other causes of dementia in Egyptian elderly 2002, (MD thesis), Geriatric Department, Ain Shams University Library.
9. Ensrud K.E., Ewing S.K., Cawthon P.M., Fink H.A., Taylor B.C., Cauely J.A., et al. Osteoporotic Fractures in Men Research Group. A comparison of frailty indexes for the prediction of falls, disability, fractures, and mortality in older men. Journal of the American Geriatrics Society 2009, 57(3):492-498.
10. Folstein M.F., Folstein S.E., McHugh P.R. "Mini-mental state": A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research 1975, 12(3):189-198.
11. Fried L.P., Kronmal R.A., Newman A.B., Bild D.E., Mittelmark M.B., Polak J.F., et al. Risk factors for 5 year mortality in older adults: The cardiovascular health study. Journal of American Medical Association 1998, 279(8):585-592.
12. Fried L.P., Tangen C.M., Walston J., Newman A.B., Hirsch C., Gottdiener J., et al. Frailty in older adults: Evidence for a phenotype. Journals of Gerontology Series A: Biological Sciences and Medical Sciences 2001, 56:146-156.
13. Fried L.P., Hadley E.C., Walston J.D., Newman A.B., Guralnik J.M., Studenski S., et al. From bedside to bench: Research agenda for frailty. Science of Aging Knowledge Environment 2005, 31:24.
14. Giustina A., Mazziotti G., Canalis E. Growth hormone, insulin-like growth factors, and the skeleton. Endocrine Reviews 2008, 29:535-559.
15. Goldspink G. Loss of muscle strength during aging studied at the gene level. Rejuvenation Research 2007, 10:397-405.
16. Jonsson K.B., Wiberg K., Ljunghall S., Ljunggren Ö. Insulin-like growth factor I does not stimulate bone resorption in cultured neonatal mouse calvarial bones. Calcified Tissue International 1996, 59:366-370.
17. Juul A. Serum levels of insulin-like growth factor I and its binding proteins in health and disease. Growth Hormone and IGF Research 2003, 13:113-170.
18. Kiely D.K., Cupples L.A., Lipsitz L.A. Validation and comparison of two frailty indexes: The MOBILIZE Boston study. Journal of the American Geriatrics Society 2009, 57(9):1532-1539.
19. Laviola L., Natalicchio A., Perrini S., Giorgino F. Abnormalities of IGF-I signaling in the pathogenesis of diseases of the bone, brain, and fetoplacental unit in humans. American Journal of Physiology: Endocrinology and Metabolism 2008, 295:991-999.
20. Li M., Li C., Parkhouse W.S. Age-related differences in the des IGF-I mediated activation of Akt-1 and p70 S6K in mouse skeletal muscle. Mechanisms of Ageing and Development 2003, 124:771-778.
21. Maggio M., Guralnik J.M., Ferrucci L. Interleukin-6 in aging and chronic disease: A magnificent pathway. Journals of Gerontology Series A: Biological Sciences and Medical Sciences 2006, 61:575-584.
22. Mathews L.S., Norstedt G., Palmiter R.D. Regulation of insulin like growth factor I gene expression by growth hormone. Proceedings of the National Academy of Sciences 1986, 83:9343-9347.
23. McKane W.R., Khosla S., Peterson J.M., Egan K., Riggs B.L. Circulating levels of cytokines that modulate bone resorption: Effects of age and menopause in women. Journal of Bone and Mineral Research 1994, 9(8):1313-1318.
24. Nowson C.A. Prevention of fractures in older people with calcium and vitamin D. Nutrients 2010, 2(9):975-984.
25. Ohlsson C., Mellström D., Carlzon D., Orwoll E., Ljunggren O., Karlsson M.K., et al. Older men with low serum IGF-1 have an increased risk of incident fractures: The MrOS Sweden study. Journal of Bone and Mineral Research 2011, 26(4):865-872.
26. Patel M.B., Arden N.K., Masterson L.M., Phillips D.I., Swaminathan R., Syddall H.E., et al. Investigating the role of the growth hormone-insulin-like growth factor (GH-IGF) axis as a determinant of male bone mineral density (BMD). Bone 2005, 37:833-841.
27. Perrini S., Laviola L., Carreira M.C., Cigarelli A., Natalicchio A., Giorgino F., et al. The GH/IGF1 axis and signaling pathways in the muscle and bone: Mechanisms underlying age-related skeletal muscle wasting and osteoporosis. Journal of Endocrinology 2010, 205(3):201-210.
28. Szulc P., Beck T.J., Marchand F., Delmas D. Low skeletal muscle mass is associated with poor structural parameters of bone and impaired balance in elderly men - The MINOS study. Journal of Bone and Mineral Research 2005, 20:721-729.
29. WHO Scientific Group on the Prevention and Management of Osteoporosis (2000: Geneva, Switzerland) Prevention and management of osteoporosis: Report of a WHO Scientific Group 2003.
30. Ziv E., Hu D. Genetic variation in insulin/IGF-1 signaling pathways and longevity. Ageing Research Reviews 2011, 10:201-204.